TANG PRIZE/Drug developed by Tang Prize laureate plays role in COVID-19 treatment
11/25/2021 04:45 PM
Tokyo, Nov. 25 (CNA) Japanese immunologist Tadamitsu Kishimoto never expected that a drug he and his research team at Osaka University developed to treat rheumatoid arthritis (RA) would one day play a role in the fight against a global pandemic.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
- Tang Prize in Rule of Law winner stresses global collaborationAmid challenges to the prevailing international order from the likes of Russia and China, 2022 Tang Prize in Rule of Law winner Cheryl Saunders said effective cross-disciplinary ...06/21/2022 04:00 PM
- Law scholar Cheryl Saunders wins Tang Prize in Rule of LawCheryl Saunders, a laureate professor emeritus at the University of Melbourne, was awarded the Tang Prize in Rule of Law on Tuesday in recognition of her decades-long studies and ...06/21/2022 11:50 AM
- Chinese characters spurred love of culture: Tang Prize Sinology winnerBritish art historian Jessica Rawson may have expressed surprise when informed that she won the 2022 Tang Prize in Sinology, but the honor represented a life-long passion for ...06/20/2022 04:12 PM
Latest
- Cross-Strait
Asymmetric warfare alone unable to cope with a Chinese attack: Experts
08/09/2022 09:37 PM - Society
Tropical Storm Mulan forms, forecast to bring heavy rain
08/09/2022 08:53 PM - Business
Central bank says its independence unrelated to earnings
08/09/2022 08:43 PM - Society
COVID-19 community screening to be suspended from Aug. 11: CECC
08/09/2022 08:34 PM - Cross-Strait
45 warplanes, 10 warships spotted near Taiwan as PLA drills continue
08/09/2022 07:59 PM